Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2007-07-10. The company specializes in stabilizing carbohydrate molecules. The company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two advanced programs are the cosmetic skin lightener and diabetes drug. Other projects include the development of an anti-aging / cell protection library, a novel anti-wrinkle compound, and the launch of an anti-viral program. Its TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. The company is focused on three antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its subsidiary is TFChem S.A.R.L.
Follow-Up Questions
¿Quién es el CEO de Sirona Biochem Corp?
Dr. Howard Y es el Chairman of the Board de Sirona Biochem Corp, se unió a la empresa desde 2020.
¿Qué tal es el rendimiento del precio de la acción SRBCF?
El precio actual de SRBCF es de $0.0103, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Sirona Biochem Corp?
Sirona Biochem Corp pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Sirona Biochem Corp?
La capitalización bursátil actual de Sirona Biochem Corp es $0
¿Es Sirona Biochem Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para Sirona Biochem Corp, incluyendo 3 fuerte compra, 5 compra, 1 mantener, 0 venta, y 3 fuerte venta
